Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2021-01-15 | 2021-05-06 | 131691 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2021-02-05 | 2021-04-29 | 133457 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2021-06-24 | 2021-07-09 | 141469 |
| TEVA-RISPERIDONE | 1.0MG | TABLET | Resolved | 2022-09-22 | 2022-12-22 | 170004 |
| TEVA-NABILONE | 1.0MG | CAPSULE | Resolved | 2022-12-01 | 2023-04-28 | 176839 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2023-04-27 | 2023-06-09 | 190671 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2023-06-16 | 2023-08-18 | 195121 |
| TEVA-AMPHETAMINE XR | 1.25MG 1.25MG 1.25MG 1.25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2018-09-12 | 2018-12-29 | 61336 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140396 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153162 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2022-05-19 | 2022-06-04 | 160997 |
| ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2020-06-04 | 2020-07-23 | 116699 |
| ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2020-12-03 | 2021-05-20 | 129530 |
| ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2023-04-27 | 2024-01-11 | 190725 |
| ACT PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195466 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-06-18 | 2019-08-06 | 86933 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-06-18 | 2020-05-01 | 86936 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-10-17 | 2020-05-21 | 96724 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-03-31 | 2022-06-17 | 157647 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-04-28 | 2022-05-26 | 159581 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |